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Introduction
It is generally agreed that scientific research should
be conducted in accordance with widely shared
ethical norms, be methodologically sound, provide
sufficient value to justify public expenditure and be
transparent (1). Research involving animals has
long been contested on ethical grounds (2), but new
to this debate are mounting evidence of poor scien-
tific method (3–7) and growing doubts about its clin-
ical value (8–11). In terms of transparency, there is
increasing acknowledgement among scientists of the
need for researchers to be more explicit when
reporting animal research in scientific publications
(12–14), and to make that research accessible and
reproducible (15). There is also a growing discourse
about the need for institutions and organisations
conducting animal research to be more open about
their activities, and for greater transparency in the
regulatory processes. Nevertheless, the most
common public perception of organisations that use
animals in research is that they are secretive (16),
and this has long been the perception in the UK (17). 
McLeod and Hobson-West (17) recently identi-
fied three key discourses relating to openness
within animal research. They suggest that: a)
animal protection groups advocate greater trans-
parency as a means of countering a secretive
system; b) the animal research community advo-
cates it as a means of countering misinformation
and misunderstanding; while c) government and
research funders argue that openness will counter
mistrust in science and government. The authors
propose that, while each of these three discourses
hopes for a different outcome as a result of greater
transparency, it is likely that together they will
challenge the status quo and put organisations to
the test. Here we consider the extent to which the
transparency agenda does challenge the status
quo, examining recent developments within the
main group representing the interests of the
sector, Understanding Animal Research (UAR),
and within the Home Office, which regulates
animal research in the UK. We propose that while
greater openness is to be welcomed, there is a
danger that this may remain too selective (18). We
suggest that public involvement may guard
against this possibility, and argue that traditional
objections to public involvement can be overcome.
Legitimacy Requires Transparency
UAR
In 2014, UAR published its Concordat on Openness
in Animal Research (19). The Concordat required
its signatories (institutions undertaking, or
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funding, animal research) to commit to enhancing
communications with the media and the public
about animal research, to be proactive in giving
the public opportunities to find out about animal
research, and to publicly acknowledge that they
conduct or fund that research. During the develop-
ment of the Concordat, the UAR commissioned
Ipsos MORI to conduct a public consultation (part
publicly-funded through the MRC), and partici-
pants were assured that their views would influ-
ence the final document (20). Consultation
participants mainly wanted external scrutiny of
the animal research sector and for the sector to
communicate more openly about its activities.
Ipsos MORI summarised the predominant view as
follows: “A prerequisite for the animal research
sector calling itself open and transparent is that it
should subject itself to external scrutiny by those
who have an interest in the animals’ welfare,
rather than by those who have a vested financial or
scientific interest in the research being carried
out” (21, p.37). The principle of public scrutiny,
however, held by participants to be the best guar-
antee of openness, did not make it into the
Concordat. 
Commentators have asked why the sector, tradi-
tionally secretive about its work, has recently
declared an interest in greater transparency (22).
One explanation is that the Concordat represents
an attempt to strengthen trust in scientists (23),
following a decline in public support for animal
research (24). However, the Nuffield Council on
Bioethics (2) has noted that a context of greater
openness also allows increased potential for a
disproportionate focus on the benefits of animal
research. Closer examination of the Concordat’s
commitment to ‘encouraging communication with
the media’ is informative. It states: “Where animal
research has played a significant role in a scientific
advancement and/or product development, we will
include information about that animal research in
relevant communications, including media
releases” (19, p.7). Clearly then, signatories
commit to communicating positive or promising
results to the media, but whether they are as
willing to communicate negative or controversial
findings in the interests of greater openness is less
apparent. As such then, increased transparency
within this context appears to provide greater
opportunity for promoting the ‘promissory
discourse’ (25), i.e. for broadcasting information
about ‘new breakthroughs’ and medical advances
that animal research will ‘one day’ bring about.
Pollock and Williams (26) argue that while
‘promissory organisations’ have the mechanisms
and networks for both communicating successful
claims and managing more contentious claims,
they not only reflect what is going on in a field, but
actively contribute to shaping expectations about
that field. Brown (27) suggests that the ‘dynamics
of expectation’, or the ‘talking up’ of biotechnology
also functions to secure resources and support for
the research.
Finally, increased openness allows for the possi-
bility of ‘normalising’ animal research, another of
UAR’s aims (28). This is achieved through
increased ‘incidental and normative’ mention of
the involvement of animals in media research
reports (29), which over time may function to
construct an appearance of consensus regarding
the legitimacy of animal research. It can be seen
then, that while UAR’s stated aim was to
strengthen public trust in scientists, additional
benefits may be gained from advocating greater
openness.
Home Office
The Home Office has similarly asserted a commit-
ment to greater transparency within animal
research. It is currently reviewing Section 24, a
privacy clause within the Animals (Scientific
Procedures) Act 1986 (ASPA), which represents the
main legal constraint against transparency in the
UK. Section 24 functions to protect scientists from
having to disclose information that they do not
wish to disclose, and is now regarded as incompat-
ible with Government policy on openness and
transparency (30), which requires more informa-
tion to be made publicly available. 
In terms of routinely available information on
UK animal research, the Home Office annual
report on the number of procedures conducted on
animals used to be all that was available. How -
ever, anonymised lay summaries of projects
licensed by the Home Office have been publicly
available since 2004 (31), and the Home Office’s
Animals in Science Regulation Unit (ASRU) has
started publishing its Annual Report (32), as well
as reports of non-compliance and selected investi-
gations of animal facilities (33). In 2015, informa-
tion on the actual (rather than predicted) severity
of each procedure was published for the first time
(34), to conform to European Directive 2010/63/
EU (35). The ASPA itself was amended in 2013,
when the European Directive, itself a driver for
greater transparency, came into force. Together,
these represent important steps toward greater
openness, but unfortunately, they are undermined
by a layer of secrecy at the very heart of the animal
research process, namely, the harm–benefit
assessment. 
In addition to holding personal and establish-
ment licences, UK animal researchers have to
apply for a Home Office project licence, which
requires them to outline the anticipated benefits of
their proposed research, together with its
predicted harms to animals. The Home Office then
conducts a harm–benefit assessment to determine
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whether the benefits are likely to outweigh the
harms. Although the harm–benefit assessment is
widely regarded as the cornerstone of the regula-
tory system, it is conducted behind closed doors,
contrary to Article 38 (4) of Directive 2010/63/EU,
that states “The project evaluation process shall be
transparent” (35). Certainly, more information on
the harm–benefit assessment is provided now than
ever before (36), both in terms of how applicants
should outline predicted harms and benefits, and
in terms of how the Home Office should come to a
judgement on them. Ultimately, however, an objec-
tive, systematic approach to weighing harms and
benefits appears to be lacking, and it remains
unclear to outsiders exactly how the assessment is
conducted in practice. The Animal Procedures
Committee (APC), which until recently advised the
Home Office on animal research, concluded that it
was primarily the project applicants who actually
conducted the assessment, with assistance from
the Home Office (37), but the Home Office asserts
that the assessment is undertaken by their inspec-
tors on the basis of information provided by appli-
cants (36). Another impediment to transparency is
the lack of clarity about whether licences are ever
refused, or whether, after modification, they are all
approved. 
The Animals in Science Committee (ASC), which
replaced the APC in 2012, was asked by Norman
Baker to review the conduct of the harm–benefit
assessment (38), but has yet to report. We suggest
that the harm–benefit assessment must be made
more transparent, not only because it represents
one of the most contentious elements of animal
research, but also because an obvious conflict of
interest exists. Project applicants have a clear
interest in their research being approved, so are
unlikely to be able to give an objective account of
its harms or benefits. Equally, it is doubtful
whether Home Office inspectors are able to take a
genuinely neutral stance, since, coming from
biomedical research backgrounds themselves (36),
they are likely to operate within the same scientific
paradigm in which animal use is taken for
granted. Furthermore, there is good evidence that
the animal research sector routinely overestimates
the significance (3, 4) and benefits (39) of animal
research.
Conversely, the sector may downplay the harms
experienced by research animals. The APC (37)
notes that some procedures with the potential to
cause substantial suffering are classified as
moderate, and Lyons (40) provides evidence for
this. He describes research involving the trans-
plantation of either pig hearts, kidneys, pancreatic
islets and/or bone into baboons or macaques, for
which the researchers proposed a ‘moderate
severity’ categorisation. This categorisation was
accepted by the Home Office, but was at odds with
the symptoms the animals displayed (documented
in leaked reports), and the fact that several were
found dead in their cages. 
Transparency Requires Public
Involvement 
As noted above, lay summaries of research
involving animals are publicly available after a
project has been approved by the Home Office.
However, because the lay summaries are anon y -
mised, they cannot be linked with the outcome of
the research in the form of publications; further-
more, because the severity category of the research
is not included in the lay summaries and there is
insufficient detail on the harms endured by
animals (41), it is not possible to identify the costs
of that research to the animals used. Con -
sequently, although lay summaries of all approved
research projects are available, the criteria needed
to form an assessment of those projects — i.e. their
harms and benefits — are lacking. It has been
argued that it is desirable, from both a moral and
a scientific standpoint, for the ethical information
associated with approved experiments (i.e. ethical
review documents, information on experimental
procedures and their severity, and considerations
of the Three Rs) to be linked with the outcomes of
those experiments (42). This would allow members
of the public to follow a research project through
from ethical review, to Home Office licensing,
publication and the outcomes and impact of that
research, providing transparency and the poss -
ibility of scrutiny.
The ex post availability of lay summaries on the
Home Office website in fact represents a compro-
mise, since, in 2003, the APC recommended
making project applications publicly available
prior to Home Office approval (37). The APC
argued that this would enable members of the
public to have input into decision-making by giving
animal protection organisations the chance to
suggest possible alternatives to research on
animals, and interested parties the opportunity to
contribute suggestions regarding the Three Rs, i.e.
the reduction, replacement and refinement of the
use of animals in research (43). In general, it was
felt that public involvement in the harm–benefit
assessment would increase confidence that the
licensing process was sufficiently rigorous (44). In
thus recommending public involvement, the APC
proposed a genuinely transparent process, as well
as indirectly acknowledging the existence of a
wealth of valuable untapped knowledge held by
expert members of the general public, animal
welfare and protection organisations, and animal
replacement scientists. 
This idea was also popular among some of
UAR’s consultation participants, who were keen
for different groups, including animal welfare and
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anti-vivisection groups, to scrutinise applications,
“…to check whether the benefits were really
likely or were simply a result of researchers
‘talking up’ their projects” (21, p.31). As the report
states, “Without evidence of this external
scrutiny, many participants felt that any other
efforts made by the sector to be open would not be
credible or convincing” (21, p.38). Such external
input would not only make the assessment more
transparent, but also, in obliging the Home Office
to consider contributions from competing value
systems and stakeholders, would provide the
opportunity for the sort of robust public engage-
ment that genuine openness surely demands. If
project applications were to be made publicly
available prior to Home Office approval, then
some practical obstacles would need to be over-
come, including how to deal with the sheer quan-
tity of applications. Perhaps, to begin with,
research categorised as ‘mild’ could be excluded.
Applications could be anonymised, if necessary.
However, public involvement might serve as an
impetus to improve the application form, which,
at present, lacks an explicit method for weighing
the harms and benefits. In general, public
scrutiny might encourage the Home Office to
make the licensing process more rigorous, robust,
explicit and objective, as it would need to be able
to defend its decisions in public.
Within clinical research, it is increasingly recog-
nised that public involvement can help ensure
research integrity, minimise adverse effects on
participants, enhance public accountability (45),
increase relevance (46) and improve research tools,
questions, processes, outcomes and implementa-
tion (47). It has been predicted that research
without evidence of public involvement will, in the
future, be considered flawed, because of the impor-
tance of transparency in maintaining public confi-
dence in it (48). Much needed improvements would
accrue from public involvement in animal
research. As well as responding to the expressed
wishes of the public, such involvement would help
to ensure bias-free transparency, legitimacy,
accountability and public trust. It would also help
to guarantee that the moral judgements inherent
in animal research reflect the values of the wider
community (49, 50). Currently, the only opportu-
nity for public involvement is as a mandatory lay-
member on an Animal Welfare and Ethical Review
Board (AWERB), to which researchers submit
their proposals before applying to the Home Office.
Such boards, however, are dominated by scientists
and do not lend themselves to equal participation
by lay-members, particularly if the latter hold
differing views about animal research (49).
Genuine opportunities for public involvement
might also lessen the likelihood of direct action.
While the latter is often cited as the reason why
animal research institutions have been secretive
(23), it could be, as Garner suggests, that “…this
style of direct action is itself, at least partly, a
product of a helplessness brought about by a
feeling that conventional politics is a waste of time,
because the odds are so stacked against animal
advocates” (51). 
Objections to public involvement include the
limits of citizen capacity, the complexity of science
and the need for professional autonomy (52). Such
objections are common in jury trials, bioethical
regulation, planning committees, mental health
and healthcare provision (53), but advances in
participatory evaluation and deliberative democ-
racy provide a way forward (54). Deliberative
forums (55), citizens’ juries (56) and democratic
governance innovations (57) facilitate open public
debate informed by guided input from experts.
Such deliberative methods have been shown to
effectively engage and educate the public (58), to
bring new solutions into existence and — seem-
ingly paradoxically — generate informed support
for professionals. As Dzur (53) argues, the very
status and authority of experts depends upon lay
involvement in some form; he proposes that knowl-
edge professions that fail to work alongside citi-
zens, seem to demand an unquestioning
compliance to authority that is unhealthy in a
democracy — this fuelling citizen disengagement
and rendering professionals vulnerable to public
scepticism about their authority, competence and
elite bias. 
Clearly there are many different ‘publics’
within this debate. Some support animal
research, some oppose it, some have a scientific
interest, and some prefer to ‘blank out’ those
aspects of life that involve animal use. For many
people, animal research is an issue that raises
profound ethical dilemmas, but one they prefer
not to dwell on. Nevertheless, many have the
impression that it is secretive and suspect that
such secrecy might be at the expense of the
animals involved (59). Even participants with
only limited knowledge and interest in the use of
animals in research are capable of developing
reasoned attitudes and conducting harm–benefit
assessments when asked to do so (60, 61). This
suggests that, given the opportunity, ‘ordinary’
citizens would be able to contribute to
harm–benefit assessments if public involvement
were a possibility. Some members of the public,
for example, patients’ groups, will have a partic-
ular interest in certain research areas and will be
motivated to participate for that reason (62).
Others may be inspired by concern for the
welfare of research animals. Expert members of
the public might wish to contribute to ideas on
the Three Rs — for example, animal replacement
scientists might want to offer information about
relevant alternatives to the methodologies
proposed. Whatever the impetus, members of the
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public, who, after all, indirectly fund most animal
research, can and should be able to scrutinise the
practices and processes of that research and hold
researchers accountable (63). Indeed, the
contested nature of animal research, together
with doubts about its clinical value and evidence
of poor research conduct in this field, make the
case for public scrutiny all the more urgent. 
Received 20.08.15; received in final form 18.01.16;
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